GBP, an Inhibitor of GSK-3, Is Implicated in Xenopus Development and Oncogenesis
Open Access
- 12 June 1998
- journal article
- research article
- Published by Elsevier
- Vol. 93 (6) , 1031-1041
- https://doi.org/10.1016/s0092-8674(00)81208-8
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- A β-catenin/XTcf-3 complex binds to thesiamois promoter to regulate dorsal axis specification in XenopusGenes & Development, 1997
- β-catenin is a target for the ubiquitin–proteasome pathwayThe EMBO Journal, 1997
- Nuclear Export of NF-ATc Enhanced by Glycogen Synthase Kinase-3Science, 1997
- Induction of the primary dorsalizing center in Xenopus by the Wnt/GSK/β-catenin signaling pathway, but not by Vg1, Activin or NogginDevelopment, 1997
- Activation ofSiamoisby theWntPathwayDevelopmental Biology, 1996
- Functional interaction of β-catenin with the transcription factor LEF-1Nature, 1996
- Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos.Proceedings of the National Academy of Sciences, 1995
- The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit.Genes & Development, 1993
- Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinaseNeuroscience Letters, 1992
- Organizing the Xenopus OrganizerPublished by Springer Nature ,1991